Diabetes epidemiology as a tool to trigger diabetes research and care P. Z. Zimmet Review Pages: 499 - 518
The impact of a family history of Type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with Type I (insulin-dependent) diabetes mellitus J. A. FageruddK. J. Pettersson-FernholmP.-H. Groop Articles Pages: 519 - 526
Effect of thiazolidinediones on expression of UCP2 and adipocyte markers in human PAZ6 adipocytes A. StrobelK. SiquierT. Issad Article Pages: 527 - 533
Exaggerated vasopressin secretion and attenuated osmoregulated thirst in human survivors of hyperosmolar coma K. McKennaA. D. MorrisC. J. Thompson Short communication Pages: 534 - 538
Evidence for iNOS-dependent peroxynitrite production in diabetic platelets M. TannousR. A. RabiniB. Mutus Short communication Pages: 539 - 544
The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction J. M. LenhardM. E. LancasterH. R. Brown Short communication Pages: 545 - 554
Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index O. RolandssonE. HäggÅ. Lernmark Short communication 1 Pages: 555 - 559
Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the unique class II MHC molecule, I-Ag7, which is also protective against the development of autoimmune diabetes X.-J. XuC. GearonM. Peakman Short communication 1 Pages: 560 - 565
Apoptosis and remodelling of beta cells by paracrine interferon-γ without insulitis in transgenic mice T. YamaokaM. YanoM. Itakura Short communication 1 Pages: 566 - 573
Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitus A. ImagawaT. HanafusaY. Matsuzawa Short communication 2 Pages: 574 - 578
Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195 K. TsuchidaZ. MakitaT. Koike Short communication 2 Pages: 579 - 588
Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus S. RudbergR. ØsterbyB. Persson Short communication 2 Pages: 589 - 595
Increased expression of endothelial antigen PAL-E in human diabetic retinopathy correlates with microvascular leakage R. O. SchlingemannP. HofmanH. G. T. Blaauwgeers Short communication 2 Pages: 596 - 602
Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Ne-(carboxymethyl) lysine independently of glycohaemoglobin concentrations H.-P. HammesM. BrownleeR. G. Bretzel Short communication 3 Pages: 603 - 607
Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43) V. HortonI. Strattonfor the UK Prospective Diabetes Study (UKPDS) Group Short communication 3 Pages: 608 - 616
Variants in the sulphonylurea receptor gene: association of the exon 16–3t variant with Type II diabetes mellitus in Dutch Caucasians L. M. ’t HartP. de KnijffJ. A. Maassen Short communication 4 Pages: 617 - 620
Three new mutations in the hepatocyte nuclear factor-1α gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization I. YoshiuchiK. YamagataY. Matsuzawa Short communication 5 Pages: 621 - 626
Reflexions on a newly discovered diabetogenic gene, wolframin (WFS1) K.-D. Gerbitz For debate Pages: 627 - 630
A common mutation of the methylenetetrahydrofolate reductase gene as a risk factor for diabetic nephropathy Letters Pages: 631 - 632
Is Trp64Arg polymorphism of β3-adrenergic receptor a clinically useful marker for the predisposition to diabetic nephropathy in Type II diabetic patients? Letters Pages: 632 - 633
Reduction of plasma leptin during a short-term fast, an oral glucose tolerance or a meal test can be a misleading bias in clinical studies Letters Pages: 634 - 634
Is the newly suggested fasting plasma glucose cut-off point for the diagnosis of diabetes the right one? Letters Pages: B635 - B636